Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina)
- PMID: 10864663
- PMCID: PMC112159
- DOI: 10.1128/jvi.74.14.6501-6510.2000
Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina)
Abstract
The increasing prevalence of human immunodeficiency virus type 1 (HIV-1) subtype C infection worldwide calls for efforts to develop a relevant animal model for evaluating strategies against the transmission of the virus. A chimeric simian/human immunodeficiency virus (SHIV), SHIV(CHN19), was generated with a primary, non-syncytium-inducing HIV-1 subtype C envelope from a Chinese strain in the background of SHIV(33). Unlike R5-tropic SHIV(162), SHIV(CHN19) was not found to replicate in rhesus CD4(+) T lymphocytes. SHIV(CHN19) does, however, replicate in CD4(+) T lymphocytes of pig-tailed macaques (Macaca nemestrina). The observed replication competence of SHIV(CHN19) requires the full tat/rev genes and partial gp41 region derived from SHIV(33). To evaluate in vivo infectivity, SHIV(CHN19) was intravenously inoculated, at first, into two pig-tailed and two rhesus macaques. Although all four animals became infected, the virus replicated preferentially in pig-tailed macaques with an earlier plasma viral peak and a faster seroconversion. To determine whether in vivo adaptation would enhance the infectivity of SHIV(CHN19), passages were carried out serially in three groups of two pig-tailed macaques each, via intravenous blood-bone marrow transfusion. The passages greatly enhanced the infectivity of the virus as shown by the increasingly elevated viral loads during acute infection in animals with each passage. Moreover, the doubling time of plasma virus during acute infection became much shorter in passage 4 (P4) animals (0.2 day) in comparison to P1 animals (1 to 2 days). P2 to P4 animals all became seropositive around 2 to 3 weeks postinoculation and had a decline in CD4/CD8 T-cell ratio during the early phase of infection. In P4 animals, a profound depletion of CD4 T cells in the lamina propria of the jejunum was observed. Persistent plasma viremia has been found in most of the infected animals with sustained viral loads ranging from 10(3) to 10(5) per ml up to 6 months postinfection. Serial passages did not change the viral phenotype as confirmed by the persistence of the R5 tropism of SHIV(CHN19) isolated from P4 animals. In addition, the infectivity of SHIV(CHN19) in rhesus peripheral blood mononuclear cells was also increased after in vivo passages. Our data indicate that SHIV(CHN19) has adapted well to grow in macaque cells. This established R5-tropic SHIV(CHN19)/macaque model would be very useful for HIV-1 subtype C vaccine and pathogenesis studies.
Figures








Similar articles
-
Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.J Virol. 2000 Sep;74(17):7851-60. doi: 10.1128/jvi.74.17.7851-7860.2000. J Virol. 2000. PMID: 10933692 Free PMC article.
-
Molecularly cloned SHIV-CN97001: a replication-competent, R5 simian/human immunodeficiency virus containing env of a primary Chinese HIV-1 clade C isolate.J Med Primatol. 2011 Dec;40(6):427-36. doi: 10.1111/j.1600-0684.2011.00497.x. Epub 2011 Sep 6. J Med Primatol. 2011. PMID: 21895680 Free PMC article.
-
Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism.J Virol. 2018 Jun 29;92(14):e02222-17. doi: 10.1128/JVI.02222-17. Print 2018 Jul 15. J Virol. 2018. PMID: 29743361 Free PMC article.
-
Understanding the basis of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus.Vaccine. 2002 May 6;20(15):1934-7. doi: 10.1016/s0264-410x(02)00072-5. Vaccine. 2002. PMID: 11983249 Review.
-
Minimally Modified HIV-1 Infection of Macaques: Development, Utility, and Limitations of Current Models.Viruses. 2024 Oct 16;16(10):1618. doi: 10.3390/v16101618. Viruses. 2024. PMID: 39459950 Free PMC article. Review.
Cited by
-
The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa.J Int AIDS Soc. 2012 Jan 26;15(1):2. doi: 10.1186/1758-2652-15-2. J Int AIDS Soc. 2012. PMID: 22281097 Free PMC article. Clinical Trial.
-
Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages.Virol J. 2007 Nov 24;4:126. doi: 10.1186/1743-422X-4-126. Virol J. 2007. PMID: 18036244 Free PMC article.
-
Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes.Virology. 2015 Jan 15;475:37-45. doi: 10.1016/j.virol.2014.10.032. Epub 2014 Nov 22. Virology. 2015. PMID: 25462344 Free PMC article.
-
Generation of lineage-related, mucosally transmissible subtype C R5 simian-human immunodeficiency viruses capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus macaques.J Virol. 2013 Jun;87(11):6137-49. doi: 10.1128/JVI.00178-13. Epub 2013 Mar 20. J Virol. 2013. PMID: 23514895 Free PMC article.
-
Conformation of HIV-1 Envelope Governs Rhesus CD4 Usage and Simian-Human Immunodeficiency Virus Replication.mBio. 2022 Feb 22;13(1):e0275221. doi: 10.1128/mbio.02752-21. Epub 2022 Jan 11. mBio. 2022. PMID: 35012342 Free PMC article.
References
-
- Abebe A, Demissie D, Goudsmit J, Brouwer M, Kuiken C L, Pollakis G, Schuitemaker H, Fontanet A L, Rinke de Wit T F. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. AIDS. 1999;13:1305–1311. - PubMed
-
- Agy M B, Frumkin L R, Corey L, Coombs R W, Wolinsky S M, Koehler J, Morton W R, Katze M G. Infection of Macaca nemestrina by human immunodeficiency virus type-1. Science. 1992;257:103–106. - PubMed
-
- Agy M B, Schmidt A, Florey M J, Kennedy B J, Schaefer G, Katze M G, Corey L, Morton W R, Bosch M L. Serial in vivo passage of HIV-1 infection in Macaca nemestrina. Virology. 1997;238:336–343. - PubMed
-
- Almond N M, Heeney J L. AIDS vaccine development in primate models. AIDS. 1998;12(Suppl. A):S133–S140. - PubMed
-
- Bjorndal A, Sonnerborg A, Tscherning C, Albert J, Fenyo E M. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res Hum Retrovir. 1999;15:647–653. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials